Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

NCT00727883 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00727883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00727883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
July 31, 2007
Completion date
May 31, 2008
Enrollment
190 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer